Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Plos One
|
May 23, 2013
Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR
Maria O'Rourke, Andreas Traweger, Lara Lusa, et al.
Plos One
|
September 10, 2015
Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings
Daša Stupica, Lara Lusa, Vera Maraspin, et al.
Plos One
|
November 22, 2013
Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model
Michael G Schwendinger, Maria O'Rourke, Andreas Traweger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 11, 2011
A new approach to a Lyme disease vaccine
Ian Livey, Maria O'Rourke, Andreas Traweger, et al.
Nursing Science Quarterly
|
March 30, 2023
A Conceptual Model for Professional Identity in Nursing: An Interdependent Perspective
M Lindell Joseph, Cole Edmonson, Nelda Godfrey, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
April 26, 2017
A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome
Doreen Schmidl, René Werkmeister, Semira Kaya, et al.
Clinical and Vaccine Immunology : CVI
|
December 26, 2014
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial
Nina Wressnigg, Maikel V W van der Velden, Daniel Portsmouth, et al.
Clinical and Vaccine Immunology : CVI
|
September 5, 2014
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato
Nina Wressnigg, P Noel Barrett, Eva-Maria Pöllabauer, et al.
Nursing Economic$
|
August 23, 2014
Excellence and evidence in staffing: a data-driven model for excellence in staffing (2nd edition)
Margarita Baggett, Joyce Batcheller, Ann Scott Blouin, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Plos One
|
May 23, 2013
Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR
Maria O'Rourke, Andreas Traweger, Lara Lusa, et al.
Plos One
|
September 10, 2015
Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings
Daša Stupica, Lara Lusa, Vera Maraspin, et al.
Plos One
|
November 22, 2013
Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model
Michael G Schwendinger, Maria O'Rourke, Andreas Traweger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 11, 2011
A new approach to a Lyme disease vaccine
Ian Livey, Maria O'Rourke, Andreas Traweger, et al.
Nursing Science Quarterly
|
March 30, 2023
A Conceptual Model for Professional Identity in Nursing: An Interdependent Perspective
M Lindell Joseph, Cole Edmonson, Nelda Godfrey, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
|
April 26, 2017
A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome
Doreen Schmidl, René Werkmeister, Semira Kaya, et al.
Clinical and Vaccine Immunology : CVI
|
December 26, 2014
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial
Nina Wressnigg, Maikel V W van der Velden, Daniel Portsmouth, et al.
Clinical and Vaccine Immunology : CVI
|
September 5, 2014
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato
Nina Wressnigg, P Noel Barrett, Eva-Maria Pöllabauer, et al.
Nursing Economic$
|
August 23, 2014
Excellence and evidence in staffing: a data-driven model for excellence in staffing (2nd edition)
Margarita Baggett, Joyce Batcheller, Ann Scott Blouin, et al.
Page
of 2